Form 4: SANUWAVE Health Director Jeffrey Blizard Acquires Stock Options

Jeffrey Blizard, a Director at SANUWAVE Health, Inc., acquired 1,574 stock options with an exercise price of $32.86, fully vested on the grant date of June 30, 2025.

Summary

• Jeffrey Blizard, a Director of SANUWAVE Health, Inc. (SNWV), acquired 1,574 stock options.
• The transaction date for the acquisition was June 30, 2025.
• Each stock option has an exercise price of $32.86.
• The acquired options were fully vested on their grant date.
• The stock options are exercisable as of June 30, 2025, and will expire on June 30, 2030.
• Following this transaction, Jeffrey Blizard directly beneficially owns 1,574 derivative securities (stock options).

Sentiment

Score: 7

Explanation: The acquisition of stock options by a director can be viewed as a positive signal, indicating alignment of interests with shareholders, though the transaction itself is routine for compensation.

Positives

• A director, Jeffrey Blizard, acquired 1,574 stock options, which can indicate alignment of interests with shareholders.
• The acquired stock options were fully vested at the grant date, providing immediate exercisability.

Future Outlook

No forward-looking statements or guidance are provided in this transaction report.

Industry Context

This document reports an individual insider transaction and does not provide information related to broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: The acquisition of stock options by a director may be perceived as a positive signal, potentially aligning management's interests with shareholder value creation.

Key Dates

Keywords

SANUWAVE Health, SNWV, Form 4, stock options, insider transaction, director, Jeffrey Blizard, equity compensation